Publications by authors named "Thomas L Smoot"

Claim this Profile
E
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studies.
Frank M P van Haren, Sarah J Valle, Ary Serpa Neto, Marcus J Schultz, John G Laffey, Thomas L Smoot

EClinicalMedicine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies.
Frank M P van Haren, John G Laffey, Antonio Artigas, Clive Page, Marcus J Schultz, Thomas L Smoot

Br J Clin Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients.
Frank M P van Haren, Lex M van Loon, Anne Steins, Thomas L Smoot, Caitlin Sas

Br J Clin Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
Frank M P van Haren, Alice Richardson, Hwan-Jin Yoon, Antonio Artigas, John G Laffey, Thomas L Smoot

Br J Clin Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis